Medtronic Plc

NYSE:MDT   3:59:59 PM EDT
-0.40 (-0.46%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)114.64B
Current PE26.40
Forward PE 16.32
2yr Forward PE 15.87
See more stats
Estimates Current Quarter
Revenue$7.53 Billion
Adjusted EPS$1.27
See more estimates
10-Day MA$84.98
50-Day MA$79.74
200-Day MA$86.83
See more pivots

Medtronic Plc Stock, NYSE:MDT

20 On Hatch, Lower Hatch Street, Dublin, Dublin 2
United States of America
Phone: +353.1.438.1700
Number of Employees: 95000


Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.